Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib gut microbiota study in psoriatic arthritis
2019-001773-90Phase 4Terminated
- Sponsor
- Sant'Andrea Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tofacitinib in psoriatic arthritis (PsA), sponsored by Sant'Andrea Hospital. Primary endpoints: Mean change from baseline in microbial diversity and Mean microbial taxonomic variation. Started Jun 2021; status: terminated.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2019-001773-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001773-90.